Enzyme specificity of proteinase inhibitor region in amyloid precursor protein of Alzheimer's disease: different properties compared with protease nexin I

Nobuya Kitaguchi, Yasuyuki Takahashi, Kiyomi Oishi, Satoshi Shiojiri, Yasuo Tokushima, Tatsuma Utsunomiya, Hirataka Ito

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Senile plaques, often surrounded by abnormally grown neurites, are characteristics of Alzheimer's diseased brain. The core of the plaque is mainly composed of amyloid β protein (β-AP), two of whose three precursors (APP) have serine proteinase inhibitor regions (APPI). APPI derivatives containing 60, 72 or 88 amino-acid fragments (APPI-60, APPI-72 and APPI-88, respectively) of the longest APP were produced in COS-1 cell culture medium, with the APPI cDNA ligated to the signal sequence of tissue plasminogen activator. The secreted APPIs were purified by sequential acetone precipitation followed by affinity chromatography using immobilized trypsin. These three APPIs and O-glycosylation- site-mutated APPI showed similar inhibitory activity against trypsin, chymotrypsin and plasmin. The purified APPI-72 was found to inhibit trypsin (Ki = 1.1 · 10-10 M) and chymotrypsin (Ki = 5.8 · 10-9 M) most strongly, and to inhibit leukocyte elastase (Ki = 7.9 · 10-7 M) and several blood coagulation proteinases (Ki = 0.46-12 · 10-7 M (Ki = 0.46-12 · 10-7 M), but not urokinase or thrombin. The observed inhibition pattern was quite different from that of protease nexin I, one of serine proteinase inhibitors possessing neurite outgrowth activity. This suggests that the physiological roles of APPI are different from those of protease nexin I, and that APPI could not cause aberrant growth of neurite into the plaque. The presence of APPI having strong inhibitory activity in the brain might lead to the formation of amyloid deposits by preventing complete degradation of APPs.

Original languageEnglish
Pages (from-to)105-113
Number of pages9
JournalBiochimica et Biophysica Acta (BBA)/Protein Structure and Molecular
Volume1038
Issue number1
DOIs
Publication statusPublished - 29-03-1990

Fingerprint

Serpin E2
Serine Proteinase Inhibitors
Amyloid beta-Protein Precursor
Amyloid Plaques
Neurites
Trypsin
Brain
Alzheimer Disease
Peptide Hydrolases
Glycosylation
Amyloidogenic Proteins
Affinity chromatography
Leukocyte Elastase
Fibrinolysin
COS Cells
Urokinase-Type Plasminogen Activator
Chymotrypsin
Blood Coagulation
Tissue Plasminogen Activator
Enzymes

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Structural Biology
  • Biochemistry
  • Molecular Biology

Cite this

Kitaguchi, Nobuya ; Takahashi, Yasuyuki ; Oishi, Kiyomi ; Shiojiri, Satoshi ; Tokushima, Yasuo ; Utsunomiya, Tatsuma ; Ito, Hirataka. / Enzyme specificity of proteinase inhibitor region in amyloid precursor protein of Alzheimer's disease : different properties compared with protease nexin I. In: Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular. 1990 ; Vol. 1038, No. 1. pp. 105-113.
@article{ab050a13e6a9444cb24f3d34d3b7b134,
title = "Enzyme specificity of proteinase inhibitor region in amyloid precursor protein of Alzheimer's disease: different properties compared with protease nexin I",
abstract = "Senile plaques, often surrounded by abnormally grown neurites, are characteristics of Alzheimer's diseased brain. The core of the plaque is mainly composed of amyloid β protein (β-AP), two of whose three precursors (APP) have serine proteinase inhibitor regions (APPI). APPI derivatives containing 60, 72 or 88 amino-acid fragments (APPI-60, APPI-72 and APPI-88, respectively) of the longest APP were produced in COS-1 cell culture medium, with the APPI cDNA ligated to the signal sequence of tissue plasminogen activator. The secreted APPIs were purified by sequential acetone precipitation followed by affinity chromatography using immobilized trypsin. These three APPIs and O-glycosylation- site-mutated APPI showed similar inhibitory activity against trypsin, chymotrypsin and plasmin. The purified APPI-72 was found to inhibit trypsin (Ki = 1.1 · 10-10 M) and chymotrypsin (Ki = 5.8 · 10-9 M) most strongly, and to inhibit leukocyte elastase (Ki = 7.9 · 10-7 M) and several blood coagulation proteinases (Ki = 0.46-12 · 10-7 M (Ki = 0.46-12 · 10-7 M), but not urokinase or thrombin. The observed inhibition pattern was quite different from that of protease nexin I, one of serine proteinase inhibitors possessing neurite outgrowth activity. This suggests that the physiological roles of APPI are different from those of protease nexin I, and that APPI could not cause aberrant growth of neurite into the plaque. The presence of APPI having strong inhibitory activity in the brain might lead to the formation of amyloid deposits by preventing complete degradation of APPs.",
author = "Nobuya Kitaguchi and Yasuyuki Takahashi and Kiyomi Oishi and Satoshi Shiojiri and Yasuo Tokushima and Tatsuma Utsunomiya and Hirataka Ito",
year = "1990",
month = "3",
day = "29",
doi = "10.1016/0167-4838(90)90017-A",
language = "English",
volume = "1038",
pages = "105--113",
journal = "Biochimica et Biophysica Acta - Proteins and Proteomics",
issn = "1570-9639",
publisher = "Elsevier",
number = "1",

}

Enzyme specificity of proteinase inhibitor region in amyloid precursor protein of Alzheimer's disease : different properties compared with protease nexin I. / Kitaguchi, Nobuya; Takahashi, Yasuyuki; Oishi, Kiyomi; Shiojiri, Satoshi; Tokushima, Yasuo; Utsunomiya, Tatsuma; Ito, Hirataka.

In: Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular, Vol. 1038, No. 1, 29.03.1990, p. 105-113.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Enzyme specificity of proteinase inhibitor region in amyloid precursor protein of Alzheimer's disease

T2 - different properties compared with protease nexin I

AU - Kitaguchi, Nobuya

AU - Takahashi, Yasuyuki

AU - Oishi, Kiyomi

AU - Shiojiri, Satoshi

AU - Tokushima, Yasuo

AU - Utsunomiya, Tatsuma

AU - Ito, Hirataka

PY - 1990/3/29

Y1 - 1990/3/29

N2 - Senile plaques, often surrounded by abnormally grown neurites, are characteristics of Alzheimer's diseased brain. The core of the plaque is mainly composed of amyloid β protein (β-AP), two of whose three precursors (APP) have serine proteinase inhibitor regions (APPI). APPI derivatives containing 60, 72 or 88 amino-acid fragments (APPI-60, APPI-72 and APPI-88, respectively) of the longest APP were produced in COS-1 cell culture medium, with the APPI cDNA ligated to the signal sequence of tissue plasminogen activator. The secreted APPIs were purified by sequential acetone precipitation followed by affinity chromatography using immobilized trypsin. These three APPIs and O-glycosylation- site-mutated APPI showed similar inhibitory activity against trypsin, chymotrypsin and plasmin. The purified APPI-72 was found to inhibit trypsin (Ki = 1.1 · 10-10 M) and chymotrypsin (Ki = 5.8 · 10-9 M) most strongly, and to inhibit leukocyte elastase (Ki = 7.9 · 10-7 M) and several blood coagulation proteinases (Ki = 0.46-12 · 10-7 M (Ki = 0.46-12 · 10-7 M), but not urokinase or thrombin. The observed inhibition pattern was quite different from that of protease nexin I, one of serine proteinase inhibitors possessing neurite outgrowth activity. This suggests that the physiological roles of APPI are different from those of protease nexin I, and that APPI could not cause aberrant growth of neurite into the plaque. The presence of APPI having strong inhibitory activity in the brain might lead to the formation of amyloid deposits by preventing complete degradation of APPs.

AB - Senile plaques, often surrounded by abnormally grown neurites, are characteristics of Alzheimer's diseased brain. The core of the plaque is mainly composed of amyloid β protein (β-AP), two of whose three precursors (APP) have serine proteinase inhibitor regions (APPI). APPI derivatives containing 60, 72 or 88 amino-acid fragments (APPI-60, APPI-72 and APPI-88, respectively) of the longest APP were produced in COS-1 cell culture medium, with the APPI cDNA ligated to the signal sequence of tissue plasminogen activator. The secreted APPIs were purified by sequential acetone precipitation followed by affinity chromatography using immobilized trypsin. These three APPIs and O-glycosylation- site-mutated APPI showed similar inhibitory activity against trypsin, chymotrypsin and plasmin. The purified APPI-72 was found to inhibit trypsin (Ki = 1.1 · 10-10 M) and chymotrypsin (Ki = 5.8 · 10-9 M) most strongly, and to inhibit leukocyte elastase (Ki = 7.9 · 10-7 M) and several blood coagulation proteinases (Ki = 0.46-12 · 10-7 M (Ki = 0.46-12 · 10-7 M), but not urokinase or thrombin. The observed inhibition pattern was quite different from that of protease nexin I, one of serine proteinase inhibitors possessing neurite outgrowth activity. This suggests that the physiological roles of APPI are different from those of protease nexin I, and that APPI could not cause aberrant growth of neurite into the plaque. The presence of APPI having strong inhibitory activity in the brain might lead to the formation of amyloid deposits by preventing complete degradation of APPs.

UR - http://www.scopus.com/inward/record.url?scp=0025230684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025230684&partnerID=8YFLogxK

U2 - 10.1016/0167-4838(90)90017-A

DO - 10.1016/0167-4838(90)90017-A

M3 - Article

C2 - 2180485

AN - SCOPUS:0025230684

VL - 1038

SP - 105

EP - 113

JO - Biochimica et Biophysica Acta - Proteins and Proteomics

JF - Biochimica et Biophysica Acta - Proteins and Proteomics

SN - 1570-9639

IS - 1

ER -